The weekly litigation news digest is live. Subscribe now

IP Verse

Bruschettini competitive analysis

Loading summary...

Latest oppositions filed by Bruschettini

Explore patent oppositions filed by Bruschettini against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2978419
Compositions For Improving Cell Viability And Methods Of Use ThereofAMYLYX PHARMACEUTICALSJan 11, 2021

Latest patents of Bruschettini opposed by its competitors

Explore Bruschettini's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3016654
Sep 5, 2018Tauroursodeoxycholic Acid (Tudca) For Use In The Treatment Of Neurodegenerative Disorders1

Latest PTAB cases involving Bruschettini

Discover the latest PTAB cases involving Bruschettini, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bruschettini with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BRUSCHETTINI11 - -
AMMELBURG6 - - -
AMYLYX PHARMACEUTICALS - 2 - -